625 related articles for article (PubMed ID: 6275607)
21. [Diagnosis and treatment of trophoblastic uterine tumors].
Kozachenko VP; Toloknov BO; Savinova VF; Grigorova TM
Vopr Onkol; 1982; 28(5):97-103. PubMed ID: 6283736
[TBL] [Abstract][Full Text] [Related]
22. Persistent trophoblast disease following partial molar pregnancy.
Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
[TBL] [Abstract][Full Text] [Related]
23. New criteria for the diagnosis of gestational trophoblastic disease.
Romero R; Horgan JG; Kohorn EI; Kadar N; Taylor KJ; Hobbins JC
Obstet Gynecol; 1985 Oct; 66(4):553-8. PubMed ID: 2995891
[TBL] [Abstract][Full Text] [Related]
24. Clinical and laboratory investigation of a virilized woman with placental-site trophoblastic tumor.
Nagelberg SB; Rosen SW
Obstet Gynecol; 1985 Apr; 65(4):527-34. PubMed ID: 2984618
[TBL] [Abstract][Full Text] [Related]
25. [Role of hysteroscopy in diagnosis and management of trophoblastic disease].
Suzuki A; Kawaguchi K; Konishi I; Ida K; Fujii S; Matsuura S
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Feb; 36(2):255-60. PubMed ID: 6321615
[TBL] [Abstract][Full Text] [Related]
26. Concentrations of SP1 and beta-hCG in serum and cerebrospinal fluid and concentrations of hCG in urine in patients with trophoblastic tumour.
Soma H; Kikuchi K; Takayama M; Saegusa H; Saito T; Kashiwagi H; Sayama S
Arch Gynecol; 1981; 230(4):321-7. PubMed ID: 6269502
[TBL] [Abstract][Full Text] [Related]
27. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases.
Cole LA; Shahabi S; Butler SA; Mitchell H; Newlands ES; Behrman HR; Verrill HL
Clin Chem; 2001 Feb; 47(2):308-15. PubMed ID: 11159780
[TBL] [Abstract][Full Text] [Related]
28. [Detection of hCG production in trophoblastic diseases by HCG beta carboxyl-terminal peptide].
Shimizu T; Matsuura S; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Oct; 35(10):1759-66. PubMed ID: 6195275
[TBL] [Abstract][Full Text] [Related]
29. [Importance of the immunologic tests for the dosage of HCG in the diagnosis of trophoblastic tumors and in the control of the therapeutic response].
Pàstina R; Domini E; Signori G
Minerva Ginecol; 1967 Sep; 19(18):933. PubMed ID: 4307545
[No Abstract] [Full Text] [Related]
30. [Experiences with the pregnancy-specific beta 1-glycoprotein (SP 1) in the diagnosis of extrauterine pregnancy in comparison with HCG determination].
Eiermann W
Gynakologe; 1983 Sep; 16(3):173-6. PubMed ID: 6196262
[No Abstract] [Full Text] [Related]
31. [Up-to-date diagnosis and therapy of trophoblastic diseases].
Gáti I
Orv Hetil; 1988 Sep; 129(38):2011-6. PubMed ID: 2845332
[No Abstract] [Full Text] [Related]
32. [Pregnancy-specific beta-1 glycoprotein (SP1) as a marker for tumors with or without trophoblastic character].
Ruibal A; Comet R; Alvarez Moro FJ; Lafuerza A; Domenech-Torné FM; Salvador L
Rev Esp Oncol; 1984; 31(3):427-34. PubMed ID: 6100801
[TBL] [Abstract][Full Text] [Related]
33. Gestational trophoblastic diseases: the ratio of choriogonadotropin to specific pregnancy protein, hCG/SP1, provides useful diagnostic and prognostic evidence.
Szymendera JJ; Ploch E; Zalucka K; Sikorowa L; Kaminska JA; Gadek A
Gynecol Oncol; 1986 Feb; 23(2):149-59. PubMed ID: 3002918
[TBL] [Abstract][Full Text] [Related]
34. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
Kohorn EI
Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394
[TBL] [Abstract][Full Text] [Related]
35. Application of the radioreceptor assay for human chorionic gonadotropin in pregnancy testing and management of trophoblastic disease.
Boyko WL; Russell HT
Obstet Gynecol; 1977 Sep; 50(3):324-32. PubMed ID: 197458
[TBL] [Abstract][Full Text] [Related]
36. Concanavalin A binding of pregnancy-specific beta-1-glycoprotein in normal pregnancy and trophoblastic disease.
Koistinen R; Heikinheimo M; Rutanen EM; Stenman UH; Lee JN; Seppälä M
Oncodev Biol Med; 1981; 2(3):179-82. PubMed ID: 6272237
[TBL] [Abstract][Full Text] [Related]
37. [The immunological determination of chorionic gonadotropins in the diagnosis, prognosis and therapeutic control of trophoblastic tumors].
Pastina R; Signori E; Domini E
Attual Ostet Ginecol; 1967; 12(4):329-36. PubMed ID: 4298895
[No Abstract] [Full Text] [Related]
38. [Expression of human chorionic gonadotropin, human placental lactogen and pregnancy-specific 1-glycoprotein in malignant trophoblastic neoplasms].
Xiong YY; Zeng J; Tang ZJ
Zhonghua Fu Chan Ke Za Zhi; 1994 Oct; 29(10):610-3, 638. PubMed ID: 7712876
[TBL] [Abstract][Full Text] [Related]
39. Circulating placental proteins (hCG, SP1 and PP5) in trophoblastic disease.
Lee JN; Salem HT; Chard T; Huang SC; Ouyang PC
Br J Obstet Gynaecol; 1982 Jan; 89(1):69-72. PubMed ID: 6277363
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemistry in the diagnosis of the gestational trophoblastic disease.
Lösch A; Kainz C
Acta Obstet Gynecol Scand; 1996 Sep; 75(8):753-6. PubMed ID: 8906012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
